SG11202100812UA - Composition for muscle relaxation - Google Patents

Composition for muscle relaxation

Info

Publication number
SG11202100812UA
SG11202100812UA SG11202100812UA SG11202100812UA SG11202100812UA SG 11202100812U A SG11202100812U A SG 11202100812UA SG 11202100812U A SG11202100812U A SG 11202100812UA SG 11202100812U A SG11202100812U A SG 11202100812UA SG 11202100812U A SG11202100812U A SG 11202100812UA
Authority
SG
Singapore
Prior art keywords
composition
muscle relaxation
relaxation
muscle
Prior art date
Application number
SG11202100812UA
Other languages
English (en)
Inventor
Yong Ji Chung
Eun Mi Kim
Eung Ji Lee
Original Assignee
Caregen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caregen Co Ltd filed Critical Caregen Co Ltd
Priority claimed from PCT/KR2019/013916 external-priority patent/WO2020138674A1/ko
Publication of SG11202100812UA publication Critical patent/SG11202100812UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Rigid Containers With Two Or More Constituent Elements (AREA)
  • Laminated Bodies (AREA)
SG11202100812UA 2018-12-26 2019-10-22 Composition for muscle relaxation SG11202100812UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180169495 2018-12-26
KR1020190083008A KR102132274B1 (ko) 2018-12-26 2019-07-10 근육 이완용 조성물
PCT/KR2019/013916 WO2020138674A1 (ko) 2018-12-26 2019-10-22 근육 이완용 조성물

Publications (1)

Publication Number Publication Date
SG11202100812UA true SG11202100812UA (en) 2021-02-25

Family

ID=71571557

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202100812UA SG11202100812UA (en) 2018-12-26 2019-10-22 Composition for muscle relaxation

Country Status (15)

Country Link
US (1) US11306121B2 (ja)
EP (1) EP3815674A4 (ja)
JP (1) JP7110405B2 (ja)
KR (1) KR102132274B1 (ja)
CN (1) CN112367967B (ja)
AR (1) AR117730A1 (ja)
BR (1) BR112020026825A2 (ja)
CA (1) CA3103204C (ja)
EA (1) EA202092820A1 (ja)
IL (1) IL279386A (ja)
MX (1) MX2020014330A (ja)
PH (1) PH12020552142A1 (ja)
SG (1) SG11202100812UA (ja)
TW (1) TWI730562B (ja)
UA (1) UA125331C2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021251789A1 (ko) * 2020-06-12 2021-12-16 (주)케어젠 펜타펩타이드를 유효성분으로 포함하는 조성물
KR102463320B1 (ko) * 2020-06-12 2022-11-07 (주)케어젠 펜타펩타이드를 유효성분으로 포함하는 통증의 완화, 예방 또는 치료용 조성물
CN114560912B (zh) * 2022-03-28 2023-10-20 碧悦星泽(北京)生物医药科技有限公司 一种具有抗皱功能的多肽及其复合物与应用
KR20230170490A (ko) * 2022-06-10 2023-12-19 (주)케어젠 근육 손실 저해 및 근육량 증진 활성을 갖는 펩타이드 및 이의 용도
WO2024122723A1 (ko) * 2022-12-09 2024-06-13 (주)케어젠 연골 재생용 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160485B1 (es) * 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
CN101687018A (zh) 2007-06-01 2010-03-31 德国麦氏大药厂 基于肉毒毒素的神经毒成分供应温度-稳定性固体肌肉松弛剂的方法
EP2173370B1 (en) * 2007-06-27 2015-10-21 The Board of Trustees of the Leland Stanford Junior University Oligopeptide tyrosinase inhibitors and uses thereof
BRPI0819063A2 (pt) * 2007-11-27 2020-08-18 The University Of British Columbia método para tratamento de artrite, anticorpo, hibridoma, antagonista de 14-3-3, usos de um antagonista de 14-3-3, composições farmacêuticas, método para redução da expressão de mmp no sinóvio de um paciente e usos de uma composição farmacêutica
GB201319621D0 (en) * 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
GB201319620D0 (en) * 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy

Also Published As

Publication number Publication date
CN112367967B (zh) 2023-04-04
EA202092820A1 (ru) 2021-02-09
EP3815674A4 (en) 2021-08-04
CA3103204A1 (en) 2020-07-02
JP2021526154A (ja) 2021-09-30
BR112020026825A2 (pt) 2021-07-27
CN112367967A (zh) 2021-02-12
KR20200080108A (ko) 2020-07-06
KR102132274B1 (ko) 2020-07-09
US20210246165A1 (en) 2021-08-12
MX2020014330A (es) 2021-03-09
IL279386A (en) 2021-01-31
PH12020552142A1 (en) 2021-06-28
AR117730A1 (es) 2021-08-25
JP7110405B2 (ja) 2022-08-01
TWI730562B (zh) 2021-06-11
CA3103204C (en) 2023-08-01
EP3815674A1 (en) 2021-05-05
UA125331C2 (uk) 2022-02-16
US11306121B2 (en) 2022-04-19
TW202024116A (zh) 2020-07-01

Similar Documents

Publication Publication Date Title
IL279386A (en) Muscle relaxant compound
GB201911800D0 (en) Antiflouling Composition
GB201820878D0 (en) Composition
GB201811100D0 (en) Composition
GB201810492D0 (en) Composition
GB2606975B (en) Composition
GB201804434D0 (en) Composition
GB2583657B (en) Composition
SG11202100685UA (en) Fat composition
GB201909924D0 (en) Composition
GB201901161D0 (en) Composition
GB201818827D0 (en) Composition
DK3573468T3 (en) Fat Composition
PL3571933T3 (pl) Kompozycja
SG11202009325YA (en) Fat composition
GB201819861D0 (en) Composition
DK3582624T3 (en) Fat composition
GB201815032D0 (en) Composition
GB201810024D0 (en) Composition
GB201809123D0 (en) Composition
GB201801596D0 (en) Composition
DK4017270T3 (en) Fat composition
GB201913398D0 (en) Composition
GB201820082D0 (en) Composition
GB201818567D0 (en) Composition